Antares makes new dermatological drug delivery system
This article was originally published in Clinica
Antares Pharma is developing a first-of-a-kind platform technology for delivering drugs into the skin. TecTix will allow topical and transmucosal delivery of active pharmaceutical agents, by reducing the melting point of the drug.
You may also be interested in...
A workshop broadcast from White Oak was a shift from the fully virtual meetings held since the height of the COVID-19 pandemic and may be a step toward once again staging public events there.
With two weeks to go before hearing on whether the preterm birth prevention drug can stay on the market or be withdrawn, the lack of clarity on who will make the ultimate decision may stem from the lengthy duration of the dispute and multiple transitions within FDA’s senior leadership.
Sumitovant offered $22.75 per share in cash, valuing Myovant at $2.4bn total, to acquire what it does not hold as a result of its 2019 agreement to buy majority shares of five Roivant companies.